tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Tim Lugo, 21 are a BUY (77.78%), 6 are a HOLD (22.22%).
Analyst Tim Lugo, currently employed at WILLIAM BLAIR, carries an average stock price target met ratio of 51.85% that have a potential upside of 44.05% achieved within 738 days.
Tim Lugo’s has documented 55 price targets and ratings displayed on 17 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on BMRN, Biomarin Pharmaceutical at 30-Oct-2024.
Analyst best performing recommendations are on ALLK (ALLAKOS).
The best stock recommendation documented was for SRPT (SAREPTA THERAPEUTICS) at 3/20/2013. The price target of $52 was fulfilled within 198 days with a profit of $19.23 (58.68%) receiving and performance score of 2.96.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$193
$88.46 (84.62%)
$200
13 days ago
(07-Nov-2024)
41/56 (73.21%)
$67.75 (54.09%)
290
Hold
$167
$62.46 (59.75%)
$152
13 days ago
(07-Nov-2024)
6/13 (46.15%)
$41.75 (33.33%)
112
Buy
$150
$45.46 (43.49%)
$103
13 days ago
(07-Nov-2024)
3/5 (60%)
$24.75 (19.76%)
274
Buy
$205
$100.46 (96.10%)
$205
13 days ago
(07-Nov-2024)
12/25 (48%)
$79.75 (63.67%)
355
Buy
$182
$77.46 (74.10%)
$182
30 days ago
(21-Oct-2024)
16/48 (33.33%)
$54.69 (42.96%)
337
Which stock is Tim Lugo is most bullish on?
Which stock is Tim Lugo is most reserved on?
What Year was the first public recommendation made by Tim Lugo?
